Marburg, Germany

Jens Huft

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 10.0

ph-index = 3

Forward Citations = 46(Granted Patents)


Location History:

  • Vancouver, CA (2017 - 2018)
  • Marburg, DE (2020 - 2022)

Company Filing History:


Years Active: 2017-2022

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Jens Huft: Innovator in Genomic Analysis

Introduction

Jens Huft is a prominent inventor based in Marburg, Germany. He has made significant contributions to the field of genomic analysis, particularly in methods for assessing genomic variation within cells. With a total of 4 patents, his work is recognized for its potential impact on cancer research and genetic diagnosis.

Latest Patents

Huft's latest patents focus on innovative methods, devices, and systems for analyzing precious samples of cells, including single cells. These inventions are designed to assess genomic heterogeneity, a critical feature in many cancers that influences disease initiation, progression, and treatment response. Additionally, his methods are utilized for analyzing embryonic biopsies for preimplantation genetic diagnosis (PGD). Notably, his inventions allow for the construction of genomic and RNA-seq libraries without a pre-amplification step, streamlining the analysis process.

Career Highlights

Jens Huft is affiliated with the University of British Columbia, where he continues to advance research in genomic analysis. His work has garnered attention for its innovative approach to understanding genetic variations and their implications in health and disease.

Collaborations

Huft collaborates with notable colleagues, including Carl Lars Genghis Hansen and Pieter Rutter Cullis. These partnerships enhance the research efforts in the field of genomic analysis and contribute to the development of cutting-edge technologies.

Conclusion

Jens Huft's contributions to genomic analysis through his patents and collaborations position him as a key figure in the field. His innovative methods have the potential to significantly impact cancer research and genetic diagnostics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…